Skip to main navigation Skip to search Skip to main content

Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone

  • Ulrike Klein
  • , Anna Jauch
  • , Thomas Hielscher
  • , Jens Hillengass
  • , Marc S Raab
  • , Anja Seckinger
  • , Dirk Hose
  • , Anthony D Ho
  • , Hartmut Goldschmidt
  • , Kai Neben

Research output: Contribution to journalArticlepeer-review

60 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone'. Together they form a unique fingerprint.
Sort by

Biochemistry, Genetics and Molecular Biology